MedPath

Financial Navigation and Peer Support to Improve Diabetes Outcomes

Not Applicable
Recruiting
Conditions
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Interventions
Behavioral: Financial Navigation Only
Behavioral: Financial Navigation and Peer Support
Registration Number
NCT06619834
Lead Sponsor
University of Michigan
Brief Summary

The goal of this clinical trial pilot study is to test the feasibility, acceptability, and preliminary efficacy of a combined intervention strategy of 1) technology-supported financial navigation to address economic burden of disease and 2) peer support both to facilitate linkages to clinical care and community resources to address social risks and improve participants\' diabetes self-management. The main aims of this pilot study are:

* To examine the feasibility and acceptability of technology-supported financial navigation and financial navigation with peer support

* To examine trends in preliminary efficacy of technology-supported financial navigation and peer support versus financial navigation-alone on 1) A1c and blood pressure (primary outcomes), and 2) out-of-pocket costs, treatment-related financial stress, cost-related non-adherence behaviors, diabetes distress, diabetes self-care behaviors, and uptake of social care assistance (secondary outcomes).

The investigators will assess whether a combined intervention of technology-supported financial navigation and peer support will produce trends in superior diabetes and social care outcomes to financial navigation alone via a 2-arm randomized controlled trial.

Participants will

* Complete 3 survey appointments at baseline, and 3 and 6 months. Each appointment will consist of a survey assessment, an HbA1C test, and two blood pressure readings over the phone.

* Be randomized to either financial navigation only or financial navigation and peer support.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
56
Inclusion Criteria

Participants:

  • 18-75 years of age
  • diagnosis of diabetes with prescribed anti-hyperglycemic medication
  • most recent (within the past 6 months) recorded hemoglobin A1c (HbA1c) level of ≥7.5% for individuals ≤70 years and >8.0% for individuals between 70-75 years in age
  • positive report of financial burden or cost-related non-adherence (CRN) using screening questions developed and validated from prior work 20-22
  • be willing to provide personal health information in order to effectively participate in the intervention

Peer Supporters:

  • International Classification of Diseases (ICD)-10 code for diabetes
  • In the past had A1cs' > 8.0% but whose most recent A1c in the prior 12 months is <8.0%.
  • Past experience with economic burden or unmet social risk factors
  • Adults 18-75 years
Exclusion Criteria

Participants:

  • a diagnosis of a serious psychiatric disorder (e.g., schizophrenia)
  • active alcohol or illicit drug use
  • current pregnancy or planning pregnancy
  • taking a medication that alters glucose metabolism (e.g., oral steroids)
  • report a comorbidity expected to limit life span to < 3 years
  • Participation in another diabetes study, but the investigators will ask them if they would like to be peer supporters

Peer Supporters:

  • A diagnosis of a serious psychiatric disorder (e.g., schizophrenia)
  • Active alcohol or illicit drug use
  • Current pregnancy or planning pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Financial Navigation onlyFinancial Navigation OnlyFinancial navigation using software called TailorMed only. The professional Financial Navigator is from the TailorMed team.
Financial Navigation and Peer SupportFinancial Navigation and Peer SupportFinancial navigation using software called TailorMed combined with peer support. The professional Financial Navigator is from the TailorMed team. Peer Supporters will be trained community members recruited from Michigan Medicine.
Primary Outcome Measures
NameTimeMethod
A1cFrom enrollment to the end of participant study duration at 6 months

Collect A1c sample using A1c Now SelfCheck test kit

Blood PressureFrom enrollment to the end of participant study duration at 6 months

Measure participant blood pressure using the Omron home blood pressure monitor. Both systolic and diastolic blood pressure will be measured.

Secondary Outcome Measures
NameTimeMethod
Uptake of social care assistanceFrom enrollment to the end of participant study duration at 6 months

Adapted from Your Current Life Situation (YCLS) and Health Leads Screening Tools

Successfully having social/financial need addressFrom enrollment to the end of participant study duration at 6 months

Enrollment data from TailorMed software

Cost-related non-adherence behaviorsFrom enrollment to the end of participant study duration at 6 months

Individual survey items adapted from National Health Interview Survey (NHIS)

Out-of-pocket costsFrom enrollment to the end of participant study duration at 6 months

Data generated from TailorMed software

Diabetes-related social supportFrom enrollment to the end of participant study duration at 6 months

Diabetes Support Scale (DSS) Minimum value- Strongly Disagree, Maximum value- Strongly Agree Higher score mean a better outcome.

Diabetes self-care behaviorsFrom enrollment to the end of participant study duration at 6 months

Diabetes Self-care Activities Scale - Adapted Minimum value- 0 Days, Maximum value- 7 Days Higher scores mean a better outcome.

Social needs screeningFrom enrollment to the end of participant study duration at 6 months

Accountable Health Communities Health-Related Social Needs Screening Tool (Q15-17) and Item adapted from National Health Interview Survey (Q18)

Adapted from Accountable Health Communities Health-Related Social Needs Screening Tool, Health Leads Social Needs Screening Toolkit, \& Kaiser Permanente Your Current Life Situation Questionnaire

Minimum value- Never True, Maximum value- Often True. Higher scores mean worse outcome.

Diabetes DistressFrom enrollment to the end of participant study duration at 6 months

Diabetes Distress Scale (DDS2 version)

Minimum Value- Not a Problem, Maximum Value- Serious Problem Higher scores mean worse outcome.

Treatment-related financial stressFrom enrollment to the end of participant study duration at 6 months

COmprehensive Score for financial Toxicity (COST)-Functional Assessment of Chronic Illness Therapy (FACIT) domains adapted for diabetes

The score includes reverse-coding 6-items, summing all items, multiplying sum by 11 and dividing the total by number of items answered. Lower scores indicate higher perceptions of financial burden. (Min value of 0, max value of 44)

Trial Locations

Locations (1)

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath